📢 Don't miss your chance to submit your abstract for #MSToronto2026! There's still time to share your work with the global #MS community at the 10th Joint ACTRIMS-ECTRIMS Meeting, taking place 21-23 October in Toronto, Canada. This year's theme: "Unifying Multiple Sclerosis." The Scientific Program Committee welcomes the submission of abstracts on the following topics: 💠 Clinical Aspects of MS 💠 Pathology and Pathogenesis of MS 💠 Imaging and Non-Imaging Biomarkers 💠 Therapy 𝐓𝐡𝐞 𝐝𝐞𝐚𝐝𝐥𝐢𝐧𝐞 𝐭𝐨 𝐬𝐮𝐛𝐦𝐢𝐭 𝐢𝐬 7 𝐌𝐚𝐲. 𝐅𝐮𝐥𝐥 𝐝𝐞𝐭𝐚𝐢𝐥𝐬 𝐡𝐞𝐫𝐞 ➡️ mstoronto2026.org/call-for-a… @ECTRIMS | @ACTRIMS #MultipleSclerosis #MSconference #MSResearch

📢 Ready to Submit a Late-Breaking Abstract? Don't miss your opportunity to present groundbreaking research to the MS community this October. The 10th Joint ACTRIMS-ECTRIMS Meeting unites researchers, clinicians and healthcare practitioners from around the world in Toronto, Canada, 21-23 October 2026. 🗓️ 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 16 𝐉𝐮𝐥𝐲 2026, 11:59 𝐏𝐌 𝐄𝐓 🔗 𝐒𝐮𝐛𝐦𝐢𝐭 𝐡𝐞𝐫𝐞: bit.ly/42PeOHv @ACTRIMS #MultipleSclerosis #MSResearch #Neurology #ECTRIMS #ACTRIMS #MSToronto2026 #ECTRIMSNextGen

📢 𝗙𝗜𝗡𝗔𝗟 𝗖𝗔𝗟𝗟! Applications for the 2026 Rachel Horne Prize for Women’s Research in MS close TODAY! This US$40,000 award honours a senior female scientist (Associate or Full Professor) for outstanding work in MS women’s health. 𝗗𝗲𝗮𝗱𝗹𝗶𝗻𝗲: 𝗧𝗼𝗱𝗮𝘆, 𝟭𝟮 𝗝𝘂𝗻𝗲 𝟮𝟬𝟮𝟲, 𝟮𝟯.𝟱𝟵 𝗽.𝗺. 𝗘𝗦𝗧 ➡️ bit.ly/4kSLbx7 #MSResearch #WomenInScience #MSToronto2026 #ECTRIMS

⏰ This week is your last chance to enroll in the MS Symptoms and Diagnosis online course (𝐎𝐩𝐞𝐧 𝐮𝐧𝐭𝐢𝐥 𝟏𝟓 𝐉𝐮𝐧𝐞 𝟐𝟎𝟐𝟔) as part of @MSIntFederation's #WorldMSDay and #MyMSDiagnosis campaign. Anyone with an interest in MS is welcome to take part, including: -People living with MS, their families and carers -Medical and nursing professionals -Allied health professionals -Advocates, service delivery staff, support workers Developed by the @ResearchMenzies in collaboration with MS International Federation (MSIF), with support from @MS_Australia and MS Plus. 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐡𝐞𝐫𝐞: worldmsday.org/online-course… #DiagnosingMS #UnderstandingMS #MultipleSclerosis #MSResearch #ECTRIMS #HCP #YoungHCP #ECTRIMSNextGen

What is it 𝘳𝘦𝘢𝘭𝘭𝘺 like to take part in an MS clinical trial? In our latest ECTRIMS Community Voices story, Helena Jidborg and George Pepper share how research involvement gave them hope, connection, and a voice in shaping the future of MS care. 𝐑𝐞𝐚𝐝 𝐦𝐨𝐫𝐞 𝐡𝐞𝐫𝐞: bit.ly/4udVZsK @shiftms @MSTrust #MSResearch #ClinicalTrials #MultipleSclerosis #ECTRIMS4me

Congratulations to the recipients of the 2026 ECTRIMS-MEDEN Fellowship in MOGAD and NMOSD Research! The joint fellowship between ECTRIMS and the MOGAD Eugene Devic European Network (MEDEN) aims to foster collaboration and research among clinicians and scientists across Europe, focusing on neuromyelitis optica spectrum disorders (NMOSD) and myelin oligodendrocyte antibody-associated disease (MOGAD). The fellowship is sponsored by @TheSumairaFDN and @AlexionPharma @AstraZeneca Rare Disease. Meet this year's fellows: 👏 Dr Silvia Bartolomeo from Italy 📍 @GreatOrmondSt Hospital for Children NHS Foundation Trust, London 🔬 The MOGAD Brain Across the Lifespan: Unravelling Whole-Brain and Regional Grey Matter Atrophy 👏 Dr Antonia Lefter from Romania 📍 Nuffield Department of Clinical Neurosciences, University of Oxford @NDCNOxford 🔬 A Cross-Sectional Analysis of the European MEDEN NMOSD and MOGAD Patients We are proud to support the next generation of researchers dedicated to improving knowledge, care, and outcomes for people living with NMOSD and MOGAD. Learn more about this year's fellowship awardees: bit.ly/49K22hE #ECTRIMSNextGen #ECTRIMS #MEDEN #NMOSD #MOGAD #Neuroimmunology #Neurology #RareDiseaseResearch

🗓️ The 31st Annual RiMS Conference is coming to Prague next week, 11-13 June! This year's theme: "Recovery and Compensation in MS Rehabilitation: Rethinking Mechanisms, Decisions, and Outcomes" Join leading experts in Prague next week! 🔗 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫: bit.ly/4utkv9Y @eurims #MSRehabilitation #RiMS2026 #ECTRIMS #Neurology #Prague

📢 Just one week days left to apply for the 2026 Rachel Horne Prize for Women’s Research in MS! 📅 𝗗𝗲𝗮𝗱𝗹𝗶𝗻𝗲: 𝟭𝟮 𝗝𝘂𝗻𝗲 𝟮𝟬𝟮𝟲 🧠 Focus for 2026: This year, the prize will recognise a senior woman neurologist or neuroscientist for her outstanding leadership, career-long achievements, and impact in advancing MS research. 📌 Why Apply? The winner will be celebrated at MSToronto, the 10th Joint ACTRIMS-ECTRIMS Meeting, held in Toronto this October. This is a unique opportunity to gain international recognition for your dedication to the MS community. 💡 How to Apply: Submit a two-page application covering: ✅ Your career context and leadership achievements ✅ Why you should be considered for the prize ✅ Your vision for the future evolution of MS research 🔗 Apply here ➡️ bit.ly/4kSLbx7 The prize is made possible through the generosity of the Horne Family Charitable Foundation, in partnership with iWiMS, ECTRIMS, and Americas Committee for Treatment & Research in Multiple Sclerosis (ACTRIMS). #RachelHornePrize #MSResearch #WomenInScience #MSToronto2026 #ECTRIMS #iWiMS @RachelHorne19

Can the revised 2024 McDonald Criteria reduce MS misdiagnosis? 🎧 In this ECTRIMS Podcast episode, recorded in collaboration with the MS Journals “Controversies in MS” series, Prof. Anneke van der Walt speaks with Prof. Andy Solomon from University of Vermont and Prof. Enrique Gomez Figueroa from Hospital Civil De Guadalajara about the promises and challenges of the revised criteria. As MS diagnosis evolves, balancing earlier diagnosis with diagnostic accuracy remains one of the field’s greatest challenges. 𝐋𝐢𝐬𝐭𝐞𝐧 𝐧𝐨𝐰: 𝐒𝐩𝐨𝐭𝐢𝐟𝐲: bit.ly/3RJywCs 𝐀𝐩𝐩𝐥𝐞: apple.co/4obJlcz 𝐖𝐞𝐛𝐬𝐢𝐭𝐞: bit.ly/4dP9ydu @MSJ_Research @uvmvermont @HospitalCivil This episode is part of the MS Journal Controversies in MS series on The revised 2024 McDonald criteria can solve the misdiagnosis problem in MS. The accompanying Yes, No, and Commentary articles are available to read open access for the next month, compliments of MS Journal. #MultipleSclerosis #McDonaldCriteria #MSDiagnosis #MSResearch #Neurology #Neuroimmunology #MRI #ECTRIMS #MultipleSclerosisJournal #ECTRIMSPodcast

Applications are now open for the 2026 @RachelHorne19 Prize in women’s MS research. US$40,000 award recognising senior female scientists. Apply by 12 June, with the winner announced at @ECTRIMS 2026. rachelhorneprize.com/

Did you publish your first #MultipleSclerosis article as first author in 2025 on our journals? Apply to the 2026 F2 Award with a cash prize and one year access to the #MSJ (stay tuned at the @ACTRIMS @ECTRIMS 2026 Closing Ceremony) ▶️ journals.sagepub.com/pb-asse… Deadline: Jul 24

On this #WorldMSDay, ECTRIMS joins the international MS community in calling for global action to improve the early and accurate diagnosis of MS. This year's theme, #MyMSDiagnosis, reminds us that early and accurate diagnosis is not just a clinical milestone. Behind every diagnosis is a person seeking clarity, answers, and timely access to care. ♦️ More than 2.9 million people worldwide live with multiple sclerosis ♦️ Every 5 minutes, someone, somewhere in the world is diagnosed with MS When we look at what shapes an MS diagnosis, the 2024 revisions to the McDonald Diagnostic Criteria represent an important step forward. The updated criteria provide healthcare professionals with more precise guidance to support earlier and more accurate MS diagnoses, incorporating new diagnostic tools and a broader understanding of how MS presents across different patient groups. ECTRIMS is committed to driving research, sharing knowledge, and improving care for people living with MS. Learn more about the revised McDonald Diagnostic Criteria: bit.ly/40rtPzz #WorldMSDay #ECTRIMS #MSIF #MultipleSclerosis #MSResearch

With #WorldMSDay taking place this weekend, Jon Strum and Dr. Nancy Sicotte sit down on @RealTalkMS_jon to discuss everything you need to know in the first 100 days after an #MSDiagnosis. From the right questions to ask, to building your care team and learning how to advocate for yourself, this episode is packed with practical guidance to help you move forward with confidence. 🎧 𝐋𝐢𝐬𝐭𝐞𝐧 𝐡𝐞𝐫𝐞: realtalkms.com/456 #MultipleSclerosis

🏆The 2026 ECTRIMS MSJ "First First Author" Awards recognise quality research from @MSJ_Research authors who published their first MS full article as first authors in 2025. This award supports early career researchers and helps share their important work at #MSToronto2026. 📩 𝐅𝐨𝐫 𝐟𝐮𝐥𝐥 𝐚𝐩𝐩𝐥𝐢𝐜𝐚𝐭𝐢𝐨𝐧 𝐝𝐞𝐭𝐚𝐢𝐥𝐬: bit.ly/4usFFW1 The MSJ & MSJ ETC Editorial Board will evaluate applications based on: • Quality of the paper • Setting of the authors • Career stage of the applicant • Number of downloads of manuscript presented • Interest of manuscript (as scored by referees) 🎖️ 𝐀𝐰𝐚𝐫𝐝𝐬: • Winner: £500 cash award 1 year MSJ access • Runner-up: 1 year MSJ access • Award ceremony at the #MSToronto2026 Closing Ceremony 🗓️ 𝐃𝐞𝐚𝐝𝐥𝐢𝐧𝐞: 𝟐𝟒 𝐉𝐮𝐥𝐲 𝟐𝟎𝟐𝟔, 𝟎𝟎:𝟎𝟎 𝐂𝐄𝐓 #MultipleSclerosis #MSResearch #ECTRIMS #MSJ #Neurology #MSToronto2026 #ECTRIMSNextGen

🔍 𝐂𝐚𝐧 𝐰𝐞 𝐫𝐞𝐯𝐞𝐫𝐬𝐞 𝐧𝐞𝐮𝐫𝐨𝐥𝐨𝐠𝐢𝐜𝐚𝐥 𝐝𝐚𝐦𝐚𝐠𝐞 𝐢𝐧 𝐌𝐒? Our latest Spotlight, 𝘚𝘵𝘰𝘱𝘱𝘪𝘯𝘨 𝘋𝘪𝘴𝘢𝘣𝘪𝘭𝘪𝘵𝘺 𝘗𝘳𝘰𝘨𝘳𝘦𝘴𝘴𝘪𝘰𝘯 𝘙𝘦𝘮𝘢𝘪𝘯𝘴 𝘵𝘩𝘦 𝘒𝘦𝘺 𝘊𝘩𝘢𝘭𝘭𝘦𝘯𝘨𝘦, explores the latest research into neuroprotection and repair in MS. 𝐑𝐞𝐚𝐝 𝐭𝐡𝐞 𝐒𝐩𝐨𝐭𝐥𝐢𝐠𝐡𝐭 𝐡𝐞𝐫𝐞: bit.ly/43mtHkU "Progression independent of disease activity is the most important problem that we need to solve," said Professor Ludwig Kappos at ECTRIMS 2025. "We observed that the infusion of autologous bone marrow was associated with reduced rate in change of the global evoked potential at 12 months," adds Dr. Claire Rice of the University of Bristol. The ECTRIMS Spotlight Series is curated and authored by our Scientific Content Writer, Stefania de Vito, PhD. #MultipleSclerosis #MSResearch #Neurology #Neuroprotection #MSSpotlight #Neuroimmunology #ECTRIMS

Is curing multiple sclerosis possible and how is a "cure" defined? CURE-MS is a study aimed at answering these questions and reaching consensus. CURE-MS is a modified Delphi panel study using a multistakeholder approach, which includes MS neurologists, patients, patient advocates and industry representatives. CURE-MS wants to hear from you! 👉redcap.uza.be/studies/survey… ⏰ The survey takes no more than 15 minutes. The pre-Delphi round is open until 31 May 2026. The steering committee of CURE-MS is comprised of: • Antonia Lefter, University of Antwerp, Belgium, University of Oxford, UK • Georgina Arrambide, CEMCAT (Centre d'Esclerosi Múltiple de Catalunya), Hospital Universitari Vall d'Hebron, Spain • Yolanda Blanco, Hospital Clínic de Barcelona, Spain • Radu Tanasescu, Nottingham University Hospitals, UK • Hélène Zéphir, CHU de Lille, France • Paola Zaratin, Italian MS Society Foundation, Italy • Barbara Willekens, UZA and University of Antwerp, Belgium All data collection and management related to this survey are handled solely by the initiative organisers. ECTRIMS is not responsible for the management of data collected through partner initiatives. #MSStudy #CUREMS #MSResearch #MS #MultipleSclerosis

Today, on International Clinical Trials Day, we recognize the essential role of clinical research in advancing multiple sclerosis care. A key goal of ECTRIMS’ mission is to actively support and coordinate initiatives in research and clinical care in Europe and worldwide. Through activities like the International Advisory Committee on Clinical Trials in MS (IACCTMS) – jointly sponsored by @ECTRIMS and the @mssociety – the MS community continues to provide guidance and perspective on the planning and implementation of clinical trials for new MS treatments. These efforts help strengthen clinical trial design, improve inclusivity, and support research that better reflects real-world patient populations and outcomes. At ECTRIMS, we are proud to support collaborative initiatives that aim to improve the quality of treatment and care for people living with MS. Learn more about the work of IACCTMS: bit.ly/43mGDqU #ClinicalTrialsDay #MSResearch #MultipleSclerosis #Neurology #ClinicalTrials #ICTD #ICTD2026

🗓️ Join leading experts in MS rehabilitation at the 31st Annual RiMS Conference in Prague, Czech Republic from 11-13 June 2026. This year's theme explores "Recovery and Compensation in MS Rehabilitation: Rethinking Mechanisms, Decisions, and Outcomes." 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 ➡️: bit.ly/4utkv9Y @eurims #MSRehabilitation #RiMS2026 #ECTRIMS #Neurology #Prague

The #MSToronto2026 scientific program is taking shape.Join global experts exploring the latest in #MSdiagnosis, imaging, biomarkers, AI, emerging therapies, pediatric MS, NMOSD, MOGAD, brain health & more.📍 Toronto virtual 📅 Oct 21–23, 2026More info: mstoronto2026.virtual-meetin…

🎉Congratulations to this year's recipients of the 2026 ECTRIMS Fellowship Awards! Our fellowship programmes help advance knowledge and expertise in the field of hashtag#MultipleSclerosis and related neurological conditions. Investing in future leaders is a core part of our mission and an important step toward advancing research, innovation, and patient care worldwide. Learn more about this year's awardees ➡️ bit.ly/3R8tpLR Meet the 2026 ECTRIMS Fellowship Award recipients: Clinical Training: Cândida Driemeyer, Andreas Liampas, & Camila Lopes Figueiredo Postdoctoral Research: Silvia Corbisiero, Hanna Frank & Anna Stölting Nurse and Allied Health Professionals Training: Elnaz Melhi Application of Magnetic Resonance Imaging Studies in MS with MAGNIMS: Mar Barrantes Cepas & Lonneke Bos (@MSIntFederation)-ECTRIMS McDonald Fellowship Programme: Reza Naeimi NMOSD and MOGAD Research: Announcement coming soon! #MSResearch #MSCommunity #Fellowships #Neurology #MS #ECTRIMSNextGen

Thrilled to be named a 2026 MSIF-ECTRIMS McDonald Fellow! Deeply grateful to MSIF and ECTRIMS for this incredible opportunity. Honored to have the chance of working with @jrplemel and his incredible team at @UAlberta. Onward to meaningful progress in MS research!